• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Ardian buys Inula in SBO

  • Francesca Veronesi
  • Francesca Veronesi
  • 04 October 2018
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Ardian has bought a majority stake in Belgium-based herbal remedies company Inula Group from Vendis Capital and management, which remain shareholders.

Ardian used its €4.5bn Ardian LBO Fund VI for the transaction, Unquote understands. The vehicle, which held a final close in 2016, targets European companies with an enterprise value between €175m-1.5bn. 

Sergio Calandri, CEO of Inula and Pranarôm's founder, Dominique Baudoux, will remain involved with the business. Vendis has retained a minority stake in the firm.

Inula

  • DEAL:

    SBO

  • LOCATION:

    Ghislenghien

  • SECTOR:

    Personal products

  • FOUNDED:

    2014

  • TURNOVER:

    €85m

  • VENDOR:

    Vendis Capital

Inula was created following the merger of Pranarôm and HerbalGem in 2014, two laboratories specialised in natural therapies, founded in 1985 and 1986 respectively.

Previous funding
Vendis became a shareholder in Pranarôm in 2011, investing alongside CEO Dominique Baudoux to support growth in Belgium and abroad. The deal was followed by the purchase of Belgian peer HerbalGem in 2014 – following the add-on the group was rebranded as Inula.

Inula bolted on Veriditas Botanicals in 2016, a US-based business founded in 1995 that sourced its natural therapy products from smaller, family-owned organic farms across the US.

Company
Inula, founded in 2014, is a herbal remedies specialist, focusing on fast-growing sub-sectors such as aromatherapy, gemmotherapy and Bach flowers, through three brands: Pranarôm (based in Ghislenghien, Belgium), HerbalGem (based in Vielsalm, Luxembourg) and Biofloral (based in Le Crouzet, France).

Inula had consolidated sales of €85m in 2017, a person familiar with the situation told Unquote. 

The group is now present in more than 25 countries, with strong market positions in France, Belgium, Spain, Italy and the US.

People
Ardian Buyout – Bruno Ladrière (managing director); Daniel Setton (director & responsible of buyout financing); Alexis Manet (senior investment manager); Rafik Alili, Edmond Delamalle (investment managers).
Vendis Capital – Cedric Olbrechts (partner); Mathieu de Medeiros (investment director).
Inula Group – Dominique Baudoux (founder, chairman).

Advisers
Vendor – JP Morgan, Edouard Debost, Peter Hujoel, Sebastien Guiol (M&A); Freshfields Bruckhaus Deringer, Vincent Macq, Frederic Elens, Elliott Fosseprez (legal); PwC, Philippe Estas, Geoffroy Jonckheere, Arnaud Chantraine, Olivier Van Crombrugge (financial due diligence); Hugues Lamon, Koen Walbers (tax); Roland Berger, Grégoire Tondreau, Patrick Biecheler, Pierre-Antoine Bodin, Jean Muraire, Yaroslav Stetsenko (strategic due diligence).
Equity – BNP Paribas Fortis, Gabriel Englebert, Pieter-Jan Van de Walle, Wide Hellemans, Elena Coluccelli-Guérin, Muriel Petit (M&A); Latham & Watkins, Olivier du Mottay, Bénédicte Bremond, Lionel Dechmann (legal), EY, Jean-Christophe Sabourin, Patrice Mottier, Tom Swinnen, Lionel Benant, Anne Dupupet, Anne-Elisabeth Combes, Maelle Duquoc (legal, tax, ESG due diligence); Siaci St Honoré, Pierre de Rochebouet, Julie Marmara, Brigitte Lalo (insurance due diligence); EY-Parthenon, Henri-Pierre Vacher, Vincent Czeszynski, Louis Ravier, Benjamin Ferrand, Fabien Bouskila (strategic due diligence).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Exits
  • Benelux
  • Consumer
  • Belgium
  • Ardian (formerly Axa PE)
  • Vendis Capital
  • Secondary buyout

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013